Canada begins review of Oxford coronavirus vaccine candidate

OTTAWA – Canada launched on Friday a real-time review of data from AstraZeneca and Oxford University’s potential COVID-19 vaccine, the latest nation to take steps to speed up the approval process as the battle against the pandemic intensifies.

Canada‘s health ministry said it received on Thursday its first submission for authorisation for the vaccine, just weeks after Health Minister Patty Hajdu signed an order in September allowing companies to submit safety and efficacy data and information as they become available.

The aim of a rolling review is to accelerate the process.

Click to play video 'Canada signs new coronavirus vaccine deals' 1:40 Canada signs new coronavirus vaccine deals

Canada signs new coronavirus vaccine deals

The news comes a day after Europe’s health regulator also started a rolling review of the first batch of data for the AstraZeneca vaccine.

The Canadian ministry will not make a decision on whether to authorize this or any other vaccine until it has received the necessary evidence to support its safety, efficacy and quality, it said.

— Reporting by Steve Scherer in Ottawa Writing by Josephine Mason in London Editing by Chizu Nomiyama and Mark Potter

© 2020 Thomson Reuters

Article Source